Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase NA 1Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Tumor-Agnostic 1

Conditions

Keratosis, Actinic 2

Interventions

Nivolumab 10pembrolizumab 6Ipilimumab 6Niacinamide 3Magnetic Resonance Spectroscopy 3Itraconazole 3Cyclophosphamide 3Biopsy 3resiquimod 2encorafenib 2durvalumab 2calcipotriene 2binimetinib 2aldesleukin 2Radiotherapy 2Oncolytic Virotherapy 2Niacin 2MART-1 Antigen 2Interleukin-2 2Imiquimod 2HhAntag691 2Fluorouracil 2Ascorbic Acid 2urelumab 1tremelimumab 1tetraethylpyrazine 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1relatlimab 1montanide ISA 51 1glucopyranosyl lipid-A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × calcipotriene × Dermatologic × Clear all
NCT03996252 2020-12-07

Combination Topical Therapy for Treatment of Scalp Actinic Keratoses

Tulane University

Phase EARLY_PHASE1 Terminated
15 enrolled
Dermatologic

Keratosis, Actinic

NCT02019355 2016-05-19

AK

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
132 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡